Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.007 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.086 | 0.008 |
mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.009 |
mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |